GSK Investigational Site

Rosenheim 83022

0 studies enrolling now · 1 studies all time

What they study most

Neoplasms

Studies at this site

• A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer — Running, not enrolling